Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Exelixis Inc., 3 years.
Exelixis Inc.
Director
Stoke Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Exelixis Inc. | Grant or award | +8,367 | — | — |
| Feb 18, 2026 | Exelixis Inc. | Option exercise | +44,087 | $19.39 | $854,847 |
| Feb 18, 2026 | Exelixis Inc. | Open-market sale | −44,087 | $44.50 | $1,961,872 |
| Feb 18, 2026 | Exelixis Inc. | Option exercise | +20,030 | $21.69 | $434,451 |
| Feb 18, 2026 | Exelixis Inc. | Open-market sale | −20,030 | $44.30 | $887,329 |
| Feb 17, 2026 | Exelixis Inc. | Option exercise | +42,422 | $18.19 | $771,656 |
| Feb 17, 2026 | Exelixis Inc. | Open-market sale | −42,422 | $43.33 | $1,838,145 |
| May 29, 2025 | Exelixis Inc. | Grant or award | +9,812 | — | — |
| Feb 28, 2025 | Exelixis Inc. | Option exercise | +19,294 | $19.77 | $381,442 |
| Feb 28, 2025 | Exelixis Inc. | Open-market sale | −19,294 | $37.62 | $725,840 |
| Feb 27, 2025 | Exelixis Inc. | Option exercise | +31,167 | $20.50 | $638,924 |
| Feb 27, 2025 | Exelixis Inc. | Option exercise | +23,347 | $19.77 | $461,570 |
| Feb 27, 2025 | Exelixis Inc. | Open-market sale | −54,514 | $38.13 | $2,078,619 |
| Aug 13, 2024 | Exelixis Inc. | Other | −4,682 | — | — |
| May 31, 2024 | Exelixis Inc. | Grant or award | +10,015 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.